Eiko Lifesciences Share Price
45.82-0.71 (-1.53%)
-11.92% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 153% | 262% |
| - | - | 121% | 164% |
| - | - | -8% | -11% |
| -24% | -24% | -33% | 8% |
Peer Comparison
Symbol
SOLARINDS-A
PIDILITIND-A
SRF-A
FLUOROCHEM-A
NAVINFLUOR-A
GODREJIND-A
DEEPAKNTR-A
AETHER-A
ATUL-A
AARTIIND-A
EIKO-X
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 21,484.05 | ₹193746 Cr | 97.29 | 72.11 | 250.42 | ₹1678 Cr |
| 1,632.9 | ₹166118 Cr | 62.71 | 8.57 | 29.91 | ₹2449 Cr |
| 2,549 | ₹77219 Cr | 35.72 | 25.6 | 102.33 | ₹1835 Cr |
| 4,520 | ₹51537 Cr | 83.8 | 20.09 | 90.49 | ₹577 Cr |
| 8,564.7 | ₹44624 Cr | 56.51 | 47.43 | 184.25 | ₹664 Cr |
| 1,165.75 | ₹38937 Cr | 33.12 | 8.44 | 50.37 | ₹1241 Cr |
| 1,715 | ₹23559 Cr | 30.08 | 25.29 | 74.81 | ₹551 Cr |
| 1,629.15 | ₹21984 Cr | 93.47 | 4.73 | 23.27 | ₹219 Cr |
| 6,400 | ₹19036 Cr | 23.93 | 83.32 | 378.24 | ₹678 Cr |
| 491 | ₹18200 Cr | 34.27 | 4.28 | 27.98 | ₹419 Cr |
| 45.82 | ₹68 Cr | 13.39 | 1.05 | 4.17 | ₹5 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹17 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹11 Cr | ₹7 Cr | ₹8 Cr | ₹11 Cr | ₹84 L | ₹56 L | ₹62 L | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹88 L | ₹1 Cr | ₹1 Cr |
| ₹41 L | ₹13 L | ₹32 L | ₹26 L | ₹27 L | ₹23 L | ₹9 L | ₹13 L | ₹26 L | ₹1 L | ₹5 L | -₹4 L | ₹1 L | ₹5 L | ₹3 L | ₹3 L | ₹0 | ₹2 L | ₹1 L |
| ₹17 Cr | ₹18 Cr | ₹12 Cr | ₹12 Cr | ₹11 Cr | ₹12 Cr | ₹8 Cr | ₹8 Cr | ₹11 Cr | ₹85 L | ₹61 L | ₹58 L | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹88 L | ₹1 Cr | ₹1 Cr |
| ₹15 Cr | ₹16 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹10 Cr | ₹7 Cr | ₹8 Cr | ₹11 Cr | ₹93 L | ₹46 L | ₹2 Cr | ₹5 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹73 L | ₹55 L | ₹66 L | -₹4 L | ₹18 L | -₹96 L | -₹1 Cr | -₹2 Cr | -₹39 L | -₹33 L | -₹12 L | -₹15 L | -₹9 L |
| ₹13 L | ₹12 L | ₹7 L | ₹10 L | ₹5 L | ₹7 L | ₹3 L | ₹4 L | ₹3 L | ₹10 L | ₹70,000 | ₹3 L | ₹8 L | ₹6 L | ₹7 L | ₹15 L | ₹2 L | ₹5 L | ₹4 L |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹54 L | ₹35 L | ₹46 L | -₹18 L | ₹14 L | -₹1 Cr | -₹1 Cr | -₹2 Cr | -₹50 L | -₹60 L | -₹18 L | -₹24 L | -₹18 L |
| ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹40 L | ₹26 L | ₹35 L | -₹13 L | ₹10 L | -₹74 L | -₹1 Cr | -₹1 Cr | -₹37 L | -₹45 L | -₹14 L | -₹17 L | -₹13 L |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|
| — | — | — | — |
| ₹14 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹43 Cr | -₹87 L | ₹1 Cr | ₹2 Cr |
| ₹43 Cr | -₹87 L | ₹1 Cr | ₹2 Cr |
| ₹57 Cr | ₹3 Cr | ₹5 Cr | ₹6 Cr |
| ₹22 L | -₹2 Cr | -₹12 L | ₹22 L |
| ₹2 Cr | ₹2 Cr | ₹42 L | ₹48 L |
| ₹82 L | -₹2 Cr | -₹27 L | ₹3 L |
| ₹3 Cr | -₹2 L | ₹15 L | ₹51 L |
| — | — | — | — |
| ₹3 Cr | ₹4 Cr | ₹1 Cr | ₹2 Cr |
| ₹2 Cr | ₹5 Cr | ₹2 Cr | ₹1 Cr |
| ₹76 L | ₹0 | ₹94 L | ₹1 Cr |
| ₹40 L | ₹4 L | ₹5 L | ₹6 L |
| ₹6 Cr | ₹9 Cr | ₹4 Cr | ₹5 Cr |
| ₹66 Cr | ₹10 Cr | ₹9 Cr | ₹11 Cr |
| ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| — | — | — | — |
| ₹26 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
| ₹3 Cr | ₹93 L | ₹74 L | ₹58 L |
| ₹23 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| ₹7 Cr | ₹10 L | ₹2 Cr | ₹3 Cr |
| ₹7 Cr | ₹10 L | ₹2 Cr | ₹3 Cr |
| ₹3 Cr | ₹2 Cr | ₹5 L | ₹4 L |
| ₹0 | ₹1 Cr | ₹1 Cr | ₹8 L |
| ₹33 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
| — | — | — | — |
| ₹6 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr |
| ₹11 Cr | ₹1 Cr | ₹86 L | ₹1 Cr |
| ₹12 Cr | ₹2 L | ₹11 L | ₹80 L |
| ₹23,000 | ₹14 L | ₹31 L | ₹4 L |
| ₹5 Cr | ₹47 L | ₹58 L | ₹57 L |
| ₹33 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr |
| ₹27 Cr | -₹4 Cr | ₹9 L | ₹1 Cr |
| ₹66 Cr | ₹10 Cr | ₹9 Cr | ₹11 Cr |
| ₹41 | ₹8 | ₹13 | ₹15 |
| ₹41 | ₹8 | ₹13 | ₹15 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|
| ₹3 Cr | -₹5 Cr | -₹100 L | ₹0 |
| -₹15 L | ₹36 L | ₹34 L | ₹0 |
| ₹32 L | ₹4 Cr | ₹84 L | ₹0 |
| ₹3 Cr | -₹30 L | ₹19 L | ₹0 |
| ₹3 Cr | -₹33 L | ₹16 L | ₹0 |
| -₹11 Cr | -₹71 L | -₹30 L | ₹0 |
| ₹7 Cr | ₹95 L | -₹55 L | ₹0 |
| -₹2 Cr | -₹9 L | -₹69 L | ₹0 |
| ₹13 Cr | ₹11 L | ₹80 L | ₹0 |
| ₹12 Cr | ₹2 L | ₹11 L | ₹0 |
Fundamental Ratios
Consolidated
Standalone
No results found